Genzyme has appointed David Meeker to the newly created role of chief operating officer, designed to establish a sharper focus on commercial execution. Dr. Meeker will be responsible for the company’s commercial organization, overseeing business units, country management organization, and global market access functions. He will work to maximize the potential of the company’s portfolio of products. By integrating all aspects of its commercial organization, the company hopes to enhance communic...